Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

DreaMed

Explore full profile

AI solutions and personalized support for optimized insulin therapy, turning real-time patient data into actionable treatment. #t1d #t2d #diabetes

Petah Tikva, IsraelFounded 2014Health Tech & Medtech
Valuation $10–25M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for DreaMed and the history behind them.

About DreaMed

DreaMed is an Israeli company founded in 2014 that operates in the digital health sector, specializing in diabetes management. The company has developed endo.digital, a cloud-based Software as a Service (SaaS) platform that functions as an AI-driven clinical decision support system for healthcare providers.

Read full description

The platform gathers data from various diabetes management devices, such as glucose monitors and insulin pumps. It then analyzes this information to provide personalized treatment recommendations for patients with diabetes. This system is designed to assist endocrinologists and other healthcare professionals in optimizing patient care and making data-informed treatment adjustments. The business model is based on subscriptions to the endo.digital platform by healthcare organizations.

The company has a history of collaboration, including a partnership with Medtronic to develop an artificial pancreas system. DreaMed has also secured multiple FDA clearances for its technology, underscoring its clinical validation.

Source: Dealroom company data

At a glance

Founded
2014
Headquarters
Petah Tikva, Israel
Sector
Health Tech & Medtech

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Medtronic
  • OurCrowd
  • The Leona M. and Harry B. Helmsley Charitable Trust

Series A2 investors entered at this stage

  • Norma Investments
  • eHealth Ventures

Talent

Book a demo to see the people
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States12.9%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about DreaMed on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DreaMed on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles